A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Insulin aspart
Selexipag
The serum concentration of Selexipag can be increased when it is combined with Afatinib.
Insulin aspart
Ombitasvir
The serum concentration of Ombitasvir can be increased when it is combined with Afatinib.
Insulin aspart
Dasabuvir
The serum concentration of Dasabuvir can be increased when it is combined with Afatinib.
Insulin aspart
Technetium Tc-99m sestamibi
The serum concentration of Technetium Tc-99m sestamibi can be increased when it is combined with Afatinib.
Insulin aspart
Nintedanib
The serum concentration of Nintedanib can be increased when it is combined with Afatinib.
Insulin aspart
Lenvatinib
The serum concentration of Lenvatinib can be increased when it is combined with Afatinib.
Insulin aspart
Umeclidinium
The serum concentration of Umeclidinium can be increased when it is combined with Afatinib.
Insulin aspart
Sofosbuvir
The serum concentration of Sofosbuvir can be increased when it is combined with Afatinib.
Insulin aspart
Dolutegravir
The serum concentration of Dolutegravir can be increased when it is combined with Afatinib.
Insulin aspart
Fostemsavir
Afatinib may decrease the excretion rate of Fostemsavir which could result in a higher serum level.
Insulin aspart
Selumetinib
Afatinib may decrease the excretion rate of Selumetinib which could result in a higher serum level.
Insulin aspart
Estradiol valerate
Estradiol valerate may decrease the excretion rate of Afatinib which could result in a higher serum level.
Insulin aspart
Estradiol dienanthate
Estradiol dienanthate may decrease the excretion rate of Afatinib which could result in a higher serum level.
Insulin aspart
Estradiol cypionate
Estradiol cypionate may decrease the excretion rate of Afatinib which could result in a higher serum level.
Insulin aspart
Estradiol benzoate
Estradiol benzoate may decrease the excretion rate of Afatinib which could result in a higher serum level.
Insulin aspart
Estradiol acetate
Estradiol acetate may decrease the excretion rate of Afatinib which could result in a higher serum level.
Insulin aspart
Paritaprevir
Paritaprevir may decrease the excretion rate of Afatinib which could result in a higher serum level.
Insulin aspart
Lusutrombopag
Afatinib may decrease the excretion rate of Lusutrombopag which could result in a higher serum level.
Insulin aspart
Tenofovir alafenamide
Afatinib may decrease the excretion rate of Tenofovir alafenamide which could result in a higher serum level.
Insulin aspart
Letermovir
Letermovir may decrease the excretion rate of Afatinib which could result in a higher serum level.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3